Literature DB >> 19077124

Intracellular mechanisms underlying the nicotinic enhancement of LTP in the rat dentate gyrus.

Philip J Welsby1, Michael J Rowan, Roger Anwyl.   

Abstract

We have previously shown that activation of nicotinic acetylcholine receptors (nAChRs) enhanced long-term potentiation (LTP) in the rat dentate gyrus in vitro via activation of alpha7 nAChR. In the present studies, mechanisms underlying the acute and chronic nicotinic enhancement of LTP were examined. In particular, the involvement of activation of intracellular kinases was examined using selective kinase antagonists, and the effects of enhancing cholinergic function with positive allosteric modulators of the alpha7 nAChR and with acetylcholinesterase (AChE) inhibitors were also investigated. Activation of extracellular signal-regulated kinase (ERK) and cAMP-dependent protein kinase (PKA) was found to be involved in the induction of the acute nicotinic enhancement of LTP, although not control LTP. In contrast, activation of the tyrosine kinase Src, Ca(2+)-calmodulin-dependent protein kinase II, Janus kinase 2 and p38 mitogen-activated protein kinase was not involved in the acute nicotinic enhancement of LTP, although Src activation was necessary for control LTP. Moreover, activation of phosphoinositide 3-kinase was involved in the acute nicotinic enhancement of LTP to a much lesser extent than in control LTP. Chronic nicotine enhancement of LTP was found to be dependent on PKA, ERK and Src kinases. Acute nicotinic enhancement of LTP was occluded by chronic nicotine treatment. The positive allosteric modulator PNU-120596 was found to strongly reduce the threshold for nicotinic enhancement of LTP, an affect mediated via the alpha7 nAChR as it was blocked by the selective antagonist methyllycaconitine. The AChE inhibitors tacrine and physostigmine enhanced control LTP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19077124     DOI: 10.1111/j.1460-9568.2008.06562.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  31 in total

1.  Nicotinic neuromodulation in auditory cortex requires MAPK activation in thalamocortical and intracortical circuits.

Authors:  Irakli Intskirveli; Raju Metherate
Journal:  J Neurophysiol       Date:  2012-02-22       Impact factor: 2.714

2.  Donepezil in a narrow concentration range augments control and impaired by beta-amyloid peptide hippocampal LTP in NMDAR-independent manner.

Authors:  Nadezhda A Kapai; Julia V Bukanova; Elena I Solntseva; Vladimir G Skrebitsky
Journal:  Cell Mol Neurobiol       Date:  2011-10-04       Impact factor: 5.046

Review 3.  Nicotinic modulation of hippocampal cell signaling and associated effects on learning and memory.

Authors:  Munir Gunes Kutlu; Thomas J Gould
Journal:  Physiol Behav       Date:  2015-12-11

4.  Presynaptic α7 nicotinic acetylcholine receptors enhance hippocampal mossy fiber glutamatergic transmission via PKA activation.

Authors:  Qing Cheng; Jerrel L Yakel
Journal:  J Neurosci       Date:  2014-01-01       Impact factor: 6.167

5.  Activation of α7 nicotinic acetylcholine receptors increases intracellular cAMP levels via activation of AC1 in hippocampal neurons.

Authors:  Qing Cheng; Jerrel L Yakel
Journal:  Neuropharmacology       Date:  2015-04-29       Impact factor: 5.250

Review 6.  Alzheimer's disease amyloid beta-protein and synaptic function.

Authors:  Tomas Ondrejcak; Igor Klyubin; Neng-Wei Hu; Andrew E Barry; William K Cullen; Michael J Rowan
Journal:  Neuromolecular Med       Date:  2009-09-16       Impact factor: 3.843

7.  Nicotine shifts the temporal activation of hippocampal protein kinase A and extracellular signal-regulated kinase 1/2 to enhance long-term, but not short-term, hippocampus-dependent memory.

Authors:  Thomas J Gould; Derek S Wilkinson; Emre Yildirim; Rachel L F Poole; Prescott T Leach; Steven J Simmons
Journal:  Neurobiol Learn Mem       Date:  2014-01-21       Impact factor: 2.877

Review 8.  Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations.

Authors:  Dustin K Williams; Jingyi Wang; Roger L Papke
Journal:  Biochem Pharmacol       Date:  2011-05-14       Impact factor: 5.858

9.  Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Aβ in vivo.

Authors:  Igor Klyubin; Tomas Ondrejcak; Jennifer Hayes; William K Cullen; Alexandra J Mably; Dominic M Walsh; Michael J Rowan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-12-02       Impact factor: 6.237

10.  Neuregulin 3 Signaling Mediates Nicotine-Dependent Synaptic Plasticity in the Orbitofrontal Cortex and Cognition.

Authors:  Luyi Zhou; Miranda L Fisher; Robert D Cole; Thomas J Gould; Vinay Parikh; Pavel I Ortinski; Jill R Turner
Journal:  Neuropsychopharmacology       Date:  2017-11-07       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.